Notably, the subsequent settlement between Novo Nordisk and Hims & Hers (under which Hims & Hers will sell branded FDA-approved semaglutide products while ceasing its advertising of compounded alternatives) suggests that at least some market participants are already adapting to this new reality
GLP-1 users who are losing weight may have higher needs
Deciding between semaglutide (Wegovy , Ozempic , Rybelsus ) and tirzepatide (Zepbound , Mounjaro ) comes down to cost, effectiveness, and personal preference
It is still in early clinical trials
On March 21, Danish company Novo Nordisks patent on semaglutide, the active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in India
For high-risk patients, doctors may prescribe mucosal protectants like Sucralfate or proton pump inhibitors like Omeprazole